COR Trading Analysis - 11/19/2026 02:38 PM — TRU-SENTIMENT

COR (Cencora Inc.) at $341.30. True Sentiment Bearish, delta 40-60 call 31% / put 69%, call $247,030 vs put $545,360. RSI 62.1.

TRU-SENTIMENT · DeltaNeutral

COR Trading Analysis - 11/19/2026 02:38 PM — TRU-SENTIMENT

Options chain · Stock chart · Baseline chart

COR (Cencora Inc.) at $341.30. True Sentiment Bearish, delta 40-60 call 31% / put 69%, call $247,030 vs put $545,360. RSI 62.1.

Symbol
COR
Price
$341.30
Article bias (separate from True Sentiment)
neutral
Conviction
low
Published
2026-11-19 14:38:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

Options flow (2026-11-19 14:38) shows Bearish sentiment: call dollar vol 247,030 (31.2%), put dollar vol 545,360 (68.8%), total 792,390. Contracts: 196 calls vs 401 puts; 5 call trades vs 1 put trade (large put block).

Conviction: Pure directional puts dominate dollar volume despite fewer trades, suggesting institutional bearish bet. Divergence: technicals bullish, options bearish — noted in spread advice "Wait for alignment".

Note: Options flow is only sentiment source; no live X posts retrieved.

Key Statistics: COR

$341.22 -1.84%
52-Week Range
$244.82 - $377.54
Market Cap
$65.11B
P/E (TTM)
19.40
PEG Ratio
N/A
Beta
0.26
Next Earnings
N/A
Avg Volume
$752,023
Dividend Yield
0.01%

Fundamental Snapshot

Valuation

P/E (trailing)19.40
EPS (trailing 12 mo)$18.03
Market cap$65.13B
Shares outstanding190.8M

Dividend

Dividend yield0.75%
Annual dividend$2.64
Ex-dividend date2026-11-13

Risk & range

Beta0.26
52-week low$244.82
52-week high$377.54
Historical volatility27.3%

Ownership & trading

Institutional ownership73.6%
Average daily volume1.4M sh

Reported figures; no analyst estimates.


📈 Analysis

News Headlines & Context

The following items are based on general knowledge and are separated from the data-driven analysis below:

  • COR (Cencora) reported fiscal Q4 2026 earnings in early November, showing steady pharmaceutical distribution revenue with margin pressure from generic drug pricing.
  • Recent sector news highlighted pharmacy supply-chain stabilization, a potential tailwind for COR's core operations.
  • Ex-dividend date of $2.64/share passed on 2026-11-13, which may have contributed to minor post-dividend price softening observed in daily data.
  • No major M&A or regulatory catalysts announced; low beta (0.26) suggests limited broad-market sensitivity.
  • Headlines imply fundamental stability, contrasting with embedded options sentiment showing bearish directional conviction.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data:

  • Trailing P/E is 19.40 with trailing EPS of 18.03; forward P/E, PEG, and profit-margin fields are null, so valuation appears moderate vs. unknown sector peers.
  • Market cap is 65.13B with 190.83M shares outstanding; institutional ownership is 73.61%, indicating strong professional holding.
  • Dividend yield is 0.75% (rate 2.64), ex-dividend 2026-11-13; beta 0.26 shows low volatility vs. market.
  • 52-week range: 244.82 to 377.54; current price (~347.62) sits in upper-mid region.
  • Revenue growth, gross/operating/net margins, ROE, debt/equity, and FCF are null — key fundamental strengths/concerns cannot be quantified from data.
  • Analyst consensus and target price are null (no recommendation key or mean target).
  • Fundamentals show stable large-cap profile with low beta, diverging from bearish options sentiment but aligning with bullish technical SMAs.

Current Market Position

From minute bars (2026-11-18 to 2026-11-19 14:10), open was 347.16, last close 341.30, with intraday low 341.30 on 2026-11-19 14:10. Daily history shows 2026-11-18 close 347.62 after range 344.49–349.84. Recent price declined from 30-day high 363.95 (2026-11-16 area) toward lower 340s.

Intraday momentum: first 5 bars held 346–347, last 5 bars drifted to 341.30 on falling volume (4,895 at final bar), indicating mild bearish intraday trend.

Resistance (Daily)
349.84
Support (Intraday)
341.30
Support (Bollinger Lower)
320.85
Resistance (Bollinger Upper)
361.70

Technical Analysis

Technical Indicators

Current Price
347.62
SMA 5
352.92
SMA 20
341.27
SMA 50
328.65
RSI 14
62.14
MACD
6.54
Signal
5.23
Hist
1.31
BB Mid
341.27
BB Up
361.70
BB Low
320.85
ATR 14
9.89

SMA alignment: 5 > 20 > 50 (352.92 > 341.27 > 328.65) — bullish stack, but price below SMA 5 signals short-term pullback. RSI 62.14 shows bullish momentum not overbought. MACD positive with histogram 1.31 confirms bullish. Bollinger mid 341.27, price above mid, inside upper/lower. 30-day range high 363.95, low 314.90; price near 95th percentile of range.

True Sentiment Analysis (Delta 40-60 Options)

Options flow (2026-11-19 14:38) shows Bearish sentiment: call dollar vol 247,030 (31.2%), put dollar vol 545,360 (68.8%), total 792,390. Contracts: 196 calls vs 401 puts; 5 call trades vs 1 put trade (large put block).

Conviction: Pure directional puts dominate dollar volume despite fewer trades, suggesting institutional bearish bet. Divergence: technicals bullish, options bearish — noted in spread advice "Wait for alignment".

Note: Options flow is only sentiment source; no live X posts retrieved.

Key Price Levels (Observational Only)

SMA 20 / BB Mid
341.27
SMA 50
328.65
SMA 5
352.92
30d High
363.95
BB Upper
361.70

Interactive charts load with JavaScript. This text is the crawlable summary.